Next Article in Journal
Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study
Next Article in Special Issue
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
Previous Article in Journal
ALK in Neuroblastoma: Biological and Therapeutic Implications
Previous Article in Special Issue
The Hippo Pathway: Immunity and Cancer
Open AccessFeature PaperReview

YAP/TAZ Activation as a Target for Treating Metastatic Cancer

Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2018, 10(4), 115; https://doi.org/10.3390/cancers10040115
Received: 19 March 2018 / Revised: 1 April 2018 / Accepted: 3 April 2018 / Published: 10 April 2018
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both emerged as important drivers of cancer progression and metastasis. YAP and TAZ are often upregulated or nuclear localized in aggressive human cancers. There is abundant experimental evidence demonstrating that YAP or TAZ activation promotes cancer formation, tumor progression, and metastasis. In this review we summarize the evidence linking YAP/TAZ activation to metastasis, and discuss the roles of YAP and TAZ during each step of the metastatic cascade. Collectively, this evidence strongly suggests that inappropriate YAP or TAZ activity plays a causal role in cancer, and that targeting aberrant YAP/TAZ activation is a promising strategy for the treatment of metastatic disease. To this end, we also discuss several potential strategies for inhibiting YAP/TAZ activation in cancer and the challenges each strategy poses. View Full-Text
Keywords: YAP; TAZ; metastasis; hippo pathway YAP; TAZ; metastasis; hippo pathway
Show Figures

Figure 1

MDPI and ACS Style

Warren, J.S.A.; Xiao, Y.; Lamar, J.M. YAP/TAZ Activation as a Target for Treating Metastatic Cancer. Cancers 2018, 10, 115.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop